NASA Tests AI Medic System for Astronauts on Deep-Space Missions
NASA is evaluating an AI-powered clinical decision support system, the Crew Medical Officer Digital Assistant (CMO-DA), designed to provide autonomous medical diagnosis and treatment recommendations for astronauts on extended deep-space voyages where Earth communication is delayed.
Tumisang Bogwasi
Tumisang Bogwasi
Washington, United States – The National Aeronautics and Space Administration (NASA) is advancing an artificial intelligence-driven clinical support system to enable astronauts to autonomously manage medical issues during long-duration deep-space missions. This Crew Medical Officer Digital Assistant (CMO-DA) aims to mitigate challenges posed by communication delays and the impracticality of emergency returns from distant space environments.
Highlights
- NASA implements AI medic system CMO-DA for autonomous astronaut healthcare beyond Earth orbit.
- The Red Hat-backed RamaLama open source tool powers the AI on an HPE Spaceborne Computer twin.
- Multimodal inference capability addresses communication latency for lunar and Mars missions.
- On-device processing ensures immediate medical guidance without reliance on Earth-based connectivity.
- Terrestrial validation precedes potential deployment to the International Space Station.
The CMO-DA system is being developed to assist crew medical officers in diagnosing and treating various symptoms that may arise during missions to the Moon, Mars, and other distant destinations. Current protocols involving communication with Earth-based medical teams become untenable as missions venture further, due to significant time delays in signal transmission.
Developed with Red Hat’s open source tool, RamaLama, the CMO-DA began as a proof of concept and has evolved into a fully disconnected edge deployment. RamaLama simplifies the process for developers to run, pull, and serve AI models, making the system adaptable for space environments.
The AI’s inference capabilities are multimodal, integrating large language models (LLMs) for complex medical reasoning and Vision Language Models (VLMs) for image-based symptom analysis. This allows the CMO-DA to process both textual and visual data efficiently without requiring extensive infrastructure, a critical factor for space-limited operations.
The system currently undergoes rigorous testing on a terrestrial replica of the HPE Spaceborne Computer, which is installed aboard the International Space Station (ISS). This testing phase on Earth is vital for refining the CMO-DA’s performance and validating its effectiveness before potential deployment to the ISS or future deep-space missions. Red Hat stated that once validated, the CMO-DA will be demonstrated to NASA leadership for further evaluation.
North America Implications
This development holds substantial implications for the North American aerospace sector, particularly for the United States. Investments in autonomous medical systems like CMO-DA underscore a strategic shift towards self-sufficiency for future human spaceflight, potentially reducing mission costs associated with emergency returns, such as the early return of Crew-11 from the ISS due to medical concerns.
The advancement of AI-driven healthcare in space could also spur innovation within terrestrial medical technology and edge computing. Companies involved in AI development, specialized hardware, and open-source platforms stand to benefit from NASA’s research and potential commercial applications.
This initiative positions the United States at the forefront of combining advanced AI with long-duration space exploration, influencing future international partnerships and standards for astronaut health and safety protocols.
